EHU016691
MISSION® esiRNA
targeting human RASA2
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
NACRES:
NA.51
UNSPSC Code:
41105324
description
Powered by Eupheria Biotech
Quality Level
product line
MISSION®
form
lyophilized powder
esiRNA cDNA target sequence
CTGTATGCCAGCAGCTTGTTGTACACATCAAGGCATGCCATGGGTTGCCTCTCATAAATGGCCAAAGCTGTGACCCTTATGCAACAGTTTCTCTAGTGGGCCCTTCTAGGAATGACCAAAAGAAGACAAAAGTAAAGAAGAAAACAAGCAATCCGCAGTTTAATGAAATCTTTTATTTTGAGGTAACCAGATCCAGTAGTTACACCAGAAAGTCCCAGTTCCAGGTAGAAGAGGAGGACATTGAAAAGCTAGAAATCAGGATCGACTTGTGGAACAATGGAAACCTAGTCCAAGATGTTTTCCTAGGTGAGATTAAGGTTCCTGTGAACGTATTAAGAACTGATTCCTCTCATCAAGCCTGGTACTTGCTACAGCCAAGAGACAATGGAAACAAGTCATCCAAAACTGATGACCTGGGGTCTCTTC
Ensembl | human accession no.
NCBI accession no.
shipped in
ambient
storage temp.
−20°C
Gene Information
human ... RASA2(5922)
General description
MISSION® esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence. These multiple silencing triggers lead to highly-specific and effective gene silencing.
For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.
For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.
Legal Information
MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany
Storage Class
10 - Combustible liquids
flash_point_f
Not applicable
flash_point_c
Not applicable
Regulatory Information
新产品
This item has
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Related Content
Instructions
Peng-Chieh Chen et al.
Proceedings of the National Academy of Sciences of the United States of America, 111(31), 11473-11478 (2014-07-23)
Noonan syndrome (NS) is a relatively common genetic disorder, characterized by typical facies, short stature, developmental delay, and cardiac abnormalities. Known causative genes account for 70-80% of clinically diagnosed NS patients, but the genetic basis for the remaining 20-30% of
Global Trade Item Number
| SKU | GTIN |
|---|---|
| EHU016691-50UG | 04061828339280 |
| EHU016691-20UG | 04061828565191 |